- Report
- August 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- October 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- August 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- August 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2023
- 50 Pages
China
From €2863EUR$3,000USD£2,399GBP
- Book
- March 2020
- 281 Pages
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Book
- December 2022
- 1376 Pages
- Book
- April 2020
- 342 Pages
- Book
- August 2019
- 456 Pages
- Book
- May 2019
- 896 Pages
- Book
- February 2025
- 160 Pages
- Book
- August 2024
- 368 Pages
- Book
- June 2021
- 866 Pages

The Chronic Kidney Disease (CKD) market is a subset of the Urology and Nephrology market. CKD is a long-term condition that affects the kidneys, and is characterized by a gradual loss of kidney function over time. It is a major cause of morbidity and mortality worldwide, and is associated with a range of other health conditions, including cardiovascular disease, diabetes, and hypertension. Treatment of CKD typically involves lifestyle modifications, medications, and dialysis.
The Urology and Nephrology market is a rapidly growing sector, driven by the increasing prevalence of CKD and other kidney-related diseases. The market is expected to benefit from the development of new treatments and technologies, as well as the increasing demand for dialysis services.
Some of the major companies in the CKD market include Baxter International, Fresenius Medical Care, DaVita, and NxStage Medical. These companies provide a range of products and services, including dialysis machines, dialysis consumables, and dialysis services. Show Less Read more